Journal of Tissue Viability

We believe that skin health and wound healing is everyone’s business and that change happens when we work together, not in silos.

About the Journal of Tissue Viability

Ever since its beginnings the Society of Tissue Viability (formerly the Tissue Viability Society / TVS) has published a scientific and clinical journal – in its first format this was called Care – Science and Practice (issued from 1981 to 1990). In 1990 the journal was renamed the Journal of Tissue Viability. Indexed in MEDLINE, PubMed, CINAHL, AMED and EMBASE this quarterly publication features a range of peer-reviewed papers. Full-text articles are available on Science Direct.

The Journal of Tissue Viability is the official publication of the Society of Tissue Viability and has been published by Elsevier since January 2008. This journal, indexed in several electronic databases, covers all aspects of the growing field of Tissue Viability. Each issue contains a mix of publications ranging from systematic reviews, reports of randomised controlled trials, laboratory studies, case series and individual patient histories. The Impact Factor of this journal is 2.4.

The Journal of Tissue Viability currently has 28 editors and editorial board members in 13 countries / regions.

Editorial board

The scientific and clinical content of the Journal of Tissue Viability is managed by an Editor and prominent Editorial Board, with all submitted manuscripts subject to review by at least two referees.


  • D. Patton – Royal College of Surgeons in Ireland, Skin Wounds and Trauma (SWaT) Research Centre, Dublin, Ireland

Associate Editors

  • P. Alves – Catholic University of Portugal – Porto Regional Centre, Porto, Portugal
  • B. M. Gillespie – Griffith University, Nathan, Queensland, Australia
  • C. Greenwood – Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

Emeritus Editors

  • M. Clark – Cardiff, United Kingdom

Editorial Board

  • D. Beekman – Örebro University, Örebro, Sweden,
  • S Browne – Department of Anatomy and Regenerative Medicine, RCSI, University of Medicine and Health Sciences, Dublin, Ireland,
  • K. Bogie – Case Western Reserve University, Cleveland, Ohio, United States of America,
  • W.P. Chaboyer – Griffith University, Faculty of Nursing And Health, Research Centre for Clinical Practice Innovation, Gold Coast, Australia,
  • T. Clark – Welsh Wound Innovation Centre, Pontyclun, United Kingdom,
  • J. Donnelly – Queen’s University Belfast, Belfast, United Kingdom,
  • L. Edsberg – Daemen University, Amherst, New York, United States of America,
  • A. Gefen – Tel Aviv University Iby and Aladar Fleischman, Faculty of Engineering, Tel Aviv, Israel,
  • E. Haesler – Curtin University, Department of Nursing Midwifery and Paramedicine, Canberra, Australian Capital Territory, Australia,
  • Y.K. Jan – University of Illinois Urbana-Champaign, Urbana, Illinois, United States of America,
  • J. Kottner – Charite University Hospital Berlin, Berlin, Germany,
  • N. Levy – University of Huddersfield, Huddersfield, United Kingdom,
  • M.D. Litchford – Case Software & Books, Greensboro, North Carolina, United States of America,
  • D. Lopez – University of A Coruna, A Coruña, Spain,
  • R. Macefield – University of Bristol, Bristol Medical School, Bristol, United Kingdom,
  • Z. Moore – Royal College of Surgeons In Ireland, Dublin, Ireland,
  • J. Nixon – University of Leeds, Leeds, United Kingdom,
  • J Lovegrove – Senior Research Fellow, Griffith University, Australia,
  • T. O Connor – Royal College of Surgeons In Ireland School of Nursing & Midwifery, Dublin, Ireland,
  • N. Ohura – Kyorin University School of Medicine, Department of Plastic, Reconstructive and Aesthetic Surgery, Tokyo, Japan,
  • A. Porter-Armstrong – Ulster University Institute of Nursing and Health Research, Londonderry, United Kingdom,
  • S Probst – Geneva School of Health Sciences, HES-SO University of Applied Sciences and Arts Western Switzerland,
  • M. Romanelli – University of Pisa, Pisa, Italy,
  • R. Samuriwo – University of Bradford, Faculty Of Health Studies, School of Nursing and Healthcare Leadership, Bradford, United Kingdom,
  • J. Swaine – The University of Western Australia, Perth, Western Australia, Australia,
  • D.J. Tobin – University College Dublin School of Medicine Charles Institute of Dermatology, Dublin, Ireland,
  • P. Wilson – Saint James’s Hospital, Clinical Specialist Podiatrist in Diabetes, Dublin, Ireland,
  • P. Worsley – University of Southampton, Southampton, United Kingdom

Journal Manager

R. Kumar Jayakumar

Member benefit

As part of our comprehensive benefits, members receive a free copy of the Journal of Tissue Viability, worth £494.00 as part of their annual subscription.

Current and back issues

If you are a member of the Society of Tissue Viability, you access the Journal by using the following steps. It is a one-time process to activate your online subscription at ScienceDirect, Elsevier’s flagship platform for peer-reviewed scholarly literature:

  1. Provide a customer reference number to validate your online subscription
    Go to, Enter your Customer Reference number and click Continue.
  2. Connect your membership identifier to a personal login
    If you have previously registered with Elsevier, enter your username and password to Login, if you are a new user, click Register Now and complete a brief registration form.

Once login/registration is complete, you will return to the ScienceDirect homepage and can use the Journal/Book title search box to access your subscription.

You can bookmark and save time accessing your subscription on future visits.

Want to get published in the Journal of Tissue Viability?

Want to get noticed by sharing your research as widely as possible? Have a great idea for a new paper? Why not submit your latest contribution?

The Journal particularly encourages papers covering skin health and wounds but will consider articles that discuss injury in any tissue. Articles that stress the multi-professional nature of tissue viability are especially welcome. The Journal actively seeks to encourage new authors as well as well-established contributors to the field – one aim of the journal is to enable all participants in tissue viability to share information with colleagues.Want a Journal that’s backed by a respected organization, with a track record of publishing high quality papers, then you’ve found the right place. Learn more about the manuscripts we consider and the submission and publication process. You can also find help at the Elsevier Researcher Academy which offers free online e-learning resources aimed at supporting researchers in their publishing activities.

Ready to submit? Use our submit a paper using Elsevier’s online submission system.

Want to become a peer reviewer of the Journal of Tissue Viability?

Anyone with skills and understanding in the field of Tissue Viability can become a peer reviewer, whether you are a nurse, allied health professional, researcher or academic.

Find out more